By PPN News Staff
Moderna has completed the Biologics License Application (BLA) to the FDA for the full licensure of its COVID-19 vaccine in individuals 18 years of age and older. As part of the completed BLA submission, Moderna has requested priority review designation.
The FDA fast-tracked designation received on May 12, 2020, has permitted Moderna to submit sections of the BLA on a rolling basis, and Moderna announced the initiation of the BLA submission on June 1, 2021.
The completed